Skip to main content
Terug
Watch Compare

PAVmed Inc.

Datakwaliteit: 100%
PAVM
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 9,24
▼ € 0,51 (-5,18%)
Marktkapitalisatie: 61,54 M
Prijs
€ 9,75
Marktkapitalisatie
61,54 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue declined -38,61% annually over 5 years
Earnings declined -98,99% over the past year
ROE of 1,14% is below average
Net margin of 564,79% shows strong profitability
Negative free cash flow of -5,24 M
P/E of 153,47 — premium valuation

Groei

Revenue Growth (5Y)
-38,61%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-97,63%
Earnings (1Y)-98,99%
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
1,14%
Boven sectorgemiddelde (-53,41%)
ROIC-56,48%
Net Margin564,79%
Op. Margin-30712,68%

Veiligheid

Debt / Equity
N/A
Current Ratio0,40
Interest Coverage-1038,38

Waardering

PE (TTM)
153,47
Boven sectorgemiddelde (-1,48)
P/B Ratio1,89
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E 153,5 -1,5
P/B 1,9 1,6
ROE % 1,1 -53,4
Net Margin % 564,8 -41,5
Rev Growth 5Y % -38,6 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -97,63% Revenue Growth (3Y) -83,15%
Earnings Growth (1Y) -98,99% Earnings Growth (3Y) N/A
Revenue Growth (5Y) -38,61% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 71.000,0 Net Income (TTM) 401.000,0
ROE 1,14% ROA 0,98%
Gross Margin N/A Operating Margin -30712,68%
Net Margin 564,79% Free Cash Flow (TTM) -5,24 M
ROIC -56,48% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,40
Interest Coverage -1038,38 Asset Turnover 0,00
Working Capital -6,27 M Tangible Book Value 32,52 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 153,47 Forward P/E N/A
P/B Ratio 1,89 P/S Ratio 866,80
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8,51%
Market Cap 61,54 M Enterprise Value 61,54 M
Per Share
EPS (Diluted TTM) -5,63 Revenue / Share 0,01
FCF / Share -0,83 OCF / Share -0,82
EPS CAGR (1Y) -1226,00% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 43,66% FCF Conversion -1305,99%
SBC-Adj. FCF -8,64 M Growth Momentum -59,02

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 71.000,0 3,00 M 2,50 M 377.000,0 500.000,0
Net Income 401.000,0 39,79 M -64,18 M -88,98 M -50,35 M
EPS (Diluted) -5,63 0,50 -9,16 — —
Gross Profit — — — — -85.000,0
Operating Income -21,81 M -44,49 M -68,80 M -90,93 M -54,39 M
EBITDA — — — — —
R&D Expenses 4,49 M 5,93 M 14,28 M 25,55 M 19,85 M
SG&A Expenses — — — — —
D&A 105.000,0 1,20 M 2,93 M 2,46 M —
Interest Expense 21.000,0 45.000,0 589.000,0 1,27 M 53.000,0
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 38,81 M 30,66 M 33,12 M 53,98 M 86,98 M
Total Liabilities 16,51 M 37,69 M 57,14 M 43,05 M 7,56 M
Shareholders' Equity 33,97 M -2,50 M -53,83 M -9,68 M 61,67 M
Total Debt — — — — —
Cash & Equivalents 1,54 M 1,19 M 19,64 M 39,74 M 77,26 M
Current Assets 2,56 M 2,16 M 24,50 M 43,93 M 82,64 M
Current Liabilities 14,84 M 35,45 M 54,18 M 41,20 M —